483
WES Pharma Inc.WES Pharma Inc. – FDA 483, Nov 21, 2023
Record Details
An FDA inspection of WES Pharma Inc., a human drug manufacturer in Westminster, MD, revealed two significant observations. The firm was cited for using inappropriate equipment design, specifically tape on a multiuse blender, and for failing to follow quality control unit procedures, including inadequate labeling of controlled substances and untimely closure of deviation investigations. These findings indicate deficiencies in maintaining proper manufacturing and quality systems.
View Company Profile
ID · c51662af-2e9d-4582-a9da-1b6e55d8dde7
Other documents for WES Pharma Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.